GR851968B - - Google Patents

Info

Publication number
GR851968B
GR851968B GR851968A GR850101968A GR851968B GR 851968 B GR851968 B GR 851968B GR 851968 A GR851968 A GR 851968A GR 850101968 A GR850101968 A GR 850101968A GR 851968 B GR851968 B GR 851968B
Authority
GR
Greece
Prior art keywords
conh
chem
disclosed
conh2
con
Prior art date
Application number
GR851968A
Other languages
English (en)
Inventor
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GR851968B publication Critical patent/GR851968B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GR851968A 1984-08-14 1985-08-12 GR851968B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001290 WO1986001107A1 (en) 1984-08-14 1984-08-14 Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making

Publications (1)

Publication Number Publication Date
GR851968B true GR851968B (el) 1985-12-13

Family

ID=22182231

Family Applications (1)

Application Number Title Priority Date Filing Date
GR851968A GR851968B (el) 1984-08-14 1985-08-12

Country Status (24)

Country Link
US (1) US4656169A (el)
EP (1) EP0173497B1 (el)
JP (1) JPS6147486A (el)
KR (1) KR870000624B1 (el)
AT (1) ATE46162T1 (el)
AU (1) AU553699B2 (el)
CA (1) CA1255304A (el)
DD (1) DD236529A5 (el)
DE (1) DE3572818D1 (el)
DK (1) DK366685A (el)
ES (2) ES8704495A1 (el)
FI (1) FI82695C (el)
GR (1) GR851968B (el)
IE (1) IE58123B1 (el)
IL (1) IL76076A0 (el)
IN (2) IN166581B (el)
NO (1) NO164101C (el)
NZ (1) NZ213085A (el)
PH (1) PH22910A (el)
PL (2) PL147875B1 (el)
PT (1) PT80940B (el)
WO (1) WO1986001107A1 (el)
YU (1) YU44894B (el)
ZA (1) ZA856102B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
AU623676B2 (en) * 1988-08-24 1992-05-21 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
TW202450B (el) * 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4193996A (en) * 1979-04-04 1980-03-18 Pfizer Inc. Spiro-quinolone hydantoins
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
IN166581B (el) 1990-06-09
EP0173497A1 (en) 1986-03-05
PH22910A (en) 1989-01-24
ES551963A0 (es) 1988-02-16
AU4612685A (en) 1986-02-20
FI82695B (fi) 1990-12-31
JPS6147486A (ja) 1986-03-07
ES8801831A1 (es) 1988-02-16
NO164101B (no) 1990-05-21
DE3572818D1 (en) 1989-10-12
FI82695C (fi) 1991-04-10
PL147875B1 (en) 1989-08-31
IE851991L (en) 1986-02-14
DD236529A5 (de) 1986-06-11
ES546093A0 (es) 1987-04-01
DK366685A (da) 1986-02-15
IL76076A0 (en) 1985-12-31
PL261413A1 (en) 1988-01-21
NO861425L (no) 1986-04-11
IN166590B (el) 1990-06-09
YU44894B (en) 1991-04-30
FI861544A0 (fi) 1986-04-11
ZA856102B (en) 1987-03-25
FI861544A (fi) 1986-04-11
AU553699B2 (en) 1986-07-24
DK366685D0 (da) 1985-08-13
NO164101C (no) 1990-08-29
JPH0339512B2 (el) 1991-06-14
KR870000624B1 (ko) 1987-03-26
CA1255304A (en) 1989-06-06
YU129085A (en) 1988-04-30
PT80940B (pt) 1987-12-30
PL254960A1 (en) 1987-01-12
NZ213085A (en) 1988-03-30
US4656169A (en) 1987-04-07
PT80940A (en) 1985-09-01
KR860001811A (ko) 1986-03-22
IE58123B1 (en) 1993-07-14
PL145221B1 (en) 1988-08-31
ES8704495A1 (es) 1987-04-01
ATE46162T1 (de) 1989-09-15
WO1986001107A1 (en) 1986-02-27
EP0173497B1 (en) 1989-09-06

Similar Documents

Publication Publication Date Title
ATE259826T1 (de) Glycinamidederivate mit funktionalisierter alkyl- und alkenylseitenkette als inhibitoren der farnesyltransferase
YU53700A (sh) Biciklo(2.2.1.) heptani i srodna jedinjenja
AU3509789A (en) Benzamide protease inhibitors
IL99536A0 (en) Isoprenoid phospholipase a2 inhibitors and pharmaceutical preparations comprising them
DE3572818D1 (en) Tetracyclic spiro-hydantoin aldose reductase inhibitors
PH17378A (en) N-naphthoylglycine derivatives and method of use thereof
MY109576A (en) Benzenealkanoic acids for cardiovascular diseases
AU6948291A (en) 1-phenylalkyl-3-phenylurea derivative
ES8500919A1 (es) Un metodo para preparar derivados de tiazolidina.
BG60208B2 (en) Process for preparingn-substituted 3-acyl-2-oxindole-1-carboxamides
JPS5692279A (en) Thiazolidine derivative